These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 20101716)

  • 1. Current treatment and recent clinical research in Alzheimer's disease.
    Neugroschl J; Sano M
    Mt Sinai J Med; 2010; 77(1):3-16. PubMed ID: 20101716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological treatment for Alzheimer's disease: current approaches and future strategies.
    Fan LY; Chiu MJ
    Acta Neurol Taiwan; 2010 Dec; 19(4):228-45. PubMed ID: 21213151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward an early diagnosis and treatment of Alzheimer's disease.
    Nordberg A
    Int Psychogeriatr; 2003 Sep; 15(3):223-37. PubMed ID: 14756159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early investigational drugs targeting tau protein for the treatment of Alzheimer's disease.
    Anand K; Sabbagh M
    Expert Opin Investig Drugs; 2015; 24(10):1355-60. PubMed ID: 26289787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigational medications for treatment of patients with Alzheimer disease.
    Potter PE
    J Am Osteopath Assoc; 2010 Sep; 110(9 Suppl 8):S27-36. PubMed ID: 20926740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
    Shoaib M; Kamal MA; Rizvi SMD
    Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic strategies for Alzheimer's disease in clinical trials.
    Godyń J; Jończyk J; Panek D; Malawska B
    Pharmacol Rep; 2016 Feb; 68(1):127-38. PubMed ID: 26721364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in the development of new drugs in Alzheimer's disease.
    Piau A; Nourhashémi F; Hein C; Caillaud C; Vellas B
    J Nutr Health Aging; 2011 Jan; 15(1):45-57. PubMed ID: 21267520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What have we learned from past failures of investigational drugs for Alzheimer's disease?
    Imbimbo BP; Watling M
    Expert Opin Investig Drugs; 2021 Dec; 30(12):1175-1182. PubMed ID: 34890262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pulse of drug development for Alzheimer's disease.
    Rafii MS
    Rev Recent Clin Trials; 2010 Jan; 5(1):57-62. PubMed ID: 20205688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical to phase II amyloid beta (A
    Parsons CG; Rammes G
    Expert Opin Investig Drugs; 2017 May; 26(5):579-592. PubMed ID: 28362514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discontinued disease-modifying therapies for Alzheimer's disease: status and future perspectives.
    Imbimbo BP; Lozupone M; Watling M; Panza F
    Expert Opin Investig Drugs; 2020 Sep; 29(9):919-933. PubMed ID: 32657175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Trends in the Management of Alzheimer's Disease: Current Therapeutic Options and Drug Repurposing Approaches.
    Singh RK
    Curr Neuropharmacol; 2020; 18(9):868-882. PubMed ID: 31989900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic Strategies Targeting Amyloid-β in Alzheimer's Disease.
    Pinheiro L; Faustino C
    Curr Alzheimer Res; 2019; 16(5):418-452. PubMed ID: 30907320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alzheimer's disease: from brain lesions to new drugs].
    Forette F; Hauw JJ
    Bull Acad Natl Med; 2008 Feb; 192(2):363-78; discussion 378-80. PubMed ID: 18819689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigational drugs in Alzheimer's disease: current progress.
    Berk C; Paul G; Sabbagh M
    Expert Opin Investig Drugs; 2014 Jun; 23(6):837-46. PubMed ID: 24702504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tau therapeutics for Alzheimer's disease: the promise and the challenges.
    Gold M
    J Mol Neurosci; 2002 Dec; 19(3):331-4. PubMed ID: 12540060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's disease failed clinical trials.
    Asher S; Priefer R
    Life Sci; 2022 Oct; 306():120861. PubMed ID: 35932841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial: Targets for Disease-Modifying Therapies in Alzheimer's Disease, Including Amyloid β and Tau Protein.
    Parums DV
    Med Sci Monit; 2021 Jul; 27():e934077. PubMed ID: 34305135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies, development, and pitfalls of therapeutic options for Alzheimer's disease.
    Haas C
    J Alzheimers Dis; 2012; 28(2):241-81. PubMed ID: 21987594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.